Drug-Drug Interaction (DDI)
4 competing products in clinical development for Drug-Drug Interaction (DDI).
Pipeline by Phase
Phase 14
All Products (4)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| EC905 + verapamil | Astellas Pharma | Phase 1 | Completed | 29 |
| rosuvastatin + fidaxomicin | Astellas Pharma | Phase 1 | Completed | 29 |
| enzalutamide + rifampin | Astellas Pharma | Phase 1 | Completed | 29 |
| ASP3652 + Gemfibrozil + Repaglinide | Astellas Pharma | Phase 1 | Completed | 29 |